Germany· DE-A57-be46acb314d9c81c
Tisseel
A medicinal product containing aprotinin, human fibrinogen, calcium chloride dihydrate, thrombin, human, human coagulation factor xiii, registered in Germany by Baxter Deutschland Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Aprotinin, Human Fibrinogen, Calcium Chloride Dihydrate, Thrombin, Human, Human Coagulation Factor Xiii
- Manufacturer
- Baxter Deutschland Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/48cf658d-81f2-4147-84cb-596119b84ac9 GET /v1/drugs/48cf658d-81f2-4147-84cb-596119b84ac9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Epilesional Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Aprotinin, Human Fibrinogen, Calcium Chloride Dihydrate, Thrombin, Human, Human Coagulation Factor Xiii",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about aprotinin, human fibrinogen, calcium chloride dihydrate, thrombin, human, human coagulation factor xiii.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.